Active agent: Timololum – 2,5 mg and 5 mg;
Excipients: a benzalkoniya chloride, povidone, dinatrium эдетат a dihydrate, dihydrophosphate sodium a dihydrate, monohydrophosphate sodium dodecahydrate, the distilled water.

Indications to use

The increased intraocular pressure (eye hypertensia);
Closed-angle glaucoma (as an additional tool for decrease in VGD along with miotika);
Secondary glaucoma;
Open angle glaucoma;
Inborn glaucoma (if other therapeutic actions are insufficiently effective).

Contraindications

Sinus bradycardia;
Chronic obstructive respiratory diseases (including bronchial asthma);
Heavy heart failure;
AV blockade of II or III degrees;
Cornea dystrophy;
Cardiogenic shock;
Allergic reactions with generalized skin rashes;
Heavy atrophic rhinitis;
Hypersensitivity to active agent (Timololum) or auxiliary components of drops.

Care is demanded by Arutimol's appointment:

Heavy cerebrovascular insufficiency;
Pulmonary insufficiency;
Diabetes mellitus;
Myasthenia;
Chronic heart failure;
Thyrotoxicosis;
Hypoglycemia;
Simultaneous use with other beta adrenoblockers.

The possibility of use of Arutimol by the feeding and pregnant women is solved the doctor individually after ratio assessment "advantage harm" for health of mother and the child.

Route of administration and dosage

Arutimol dig in in a conjunctival sac of the affected eye on 1 drop twice a day. After stabilization of a state frequency rate of use of drops is reduced to 1 time a day.

Means is intended for prolonged use. It is possible to interrupt the appointed treatment or to change a dosage only on doctor's orders.

Side effects

At Arutimol's use there can be various side effects:

Respiratory system: bronchospasm, asthma, pulmonary insufficiency;
Organ of sight: a photophobia, a cornea giposteziya, irritation, a hyperemia of a conjunctiva and skin a century, a dot superficial keratopathy, a ptosis, burning and an itch in eyes, dacryagogue, a diplopia, cornea epithelium hypostasis, a xerophthalmus;
Central and peripheral nervous system: dizziness, headache, depression, weakness, paresthesias;
Cardiovascular system: lowering of arterial pressure, bradycardia, heart failure, cardiac standstill, bradyarrhythmia, collapse, AV blockade, passing disturbances of cerebral circulation;
Alimentary system: diarrhea, nausea.

With hypersensitivity development of allergic reactions in the form of eczema and urticaria is possible. Also during therapy by Arutimol emergence of rhinitis, an alopecia and disturbances of sexual functions is possible.

The main symptoms of overdose are nausea, dizziness, a bronchospasm, a headache, bradycardia, arrhythmia, vomiting. For treatment it is necessary to wash out eyes normal saline solution or water and, if necessary, to carry out symptomatic therapy.

Special instructions

To avoid adjournment of preservative in contact lenses, they should be removed before the procedure and to establish 15 minutes later after an instillation.

It is impossible to dig in at the same time in eyes two drugs of beta adrenoblocker.

In case of the forthcoming operation using the general anesthesia Arutimol's reception should be cancelled for two days.

Right after an instillation decrease in clearness of sight and delay of speed of psychomotor reactions can be observed that needs to be considered when performing potentially dangerous types of works. The effect amplifies at alcohol intake.

Analogs

Arutimol's analogs are:

On active agent: Okuker, Timogeksal, Timadren, Okumol, Timolollong, Glautam, Niolol, Okumed, Timololum, Okupres-E, Oftan;
On the action mechanism: Ksalak, Betoptik, Ganfort, Ksonef, Duotrav, Kombigan, Azarga, Anaprilin, Duoprost, Betoftan, Optibetol, Betaksolol.